Nektar Therapeutics (NKTR)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Nektar Therapeutics-Aktie (NKTR)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	5.50% 11.79	11.18	10.46	29.18	24.12
Cost Of Revenue	-	-	-	7.977	4.435
Operating Expenses	8.32% 43.46	47.41	54.99	6.85	54.03
Benefits Costs and Expenses	7.43% 46.81	50.57	56.83	22.17	61.17
Costs And Expenses	8.32% 43.46	47.41	54.99	14.83	58.47
Depreciation and Amortization	8.41% 0.196	0.214	0.426	0.332	0.993
Operating Income/Loss	12.58% -31.67	-36.23	-44.53	14.35	-34.34
Nonoperating Income/Loss	5.81% -3.349	-3.165	-1.834	-7.346	-2.703
Income/Loss Before Equity Method Investments	11.10% -35.02	-39.40	-46.37	-	-
Income/Loss From Equity Method Investments	77.62% -0.534	-2.386	-4.461	-	-
Income/Loss From Continuing Operations Before Tax	11.10% -35.02	-39.40	-46.37	7.002	-37.05
Income Tax Expense/Benefit	82.45% -0.033	-0.188	0.052	-0.259	0.009
Income/Loss From Continuing Operations After Tax	10.76% -34.99	-39.21	-46.42	7.261	-37.06
Net Income/Loss	14.60% -35.52	-41.59	-50.88	7.261	-37.06
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	34.49% 18.95	14.09	210.92	1.369	209.25
Diluted Average Shares	34.49% 18.95	14.09	210.92	1.369	209.25
Basic Earnings Per Share	36.61% -1.87	-2.95	-0.24	0.04	-0.18
Diluted Earnings Per Share	36.61% -1.87	-2.95	-0.24	0.04	-0.18
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%